Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403831 | 12540383 | 1 | I | 20160610 | 20160708 | 20160708 | PER | US-PFIZER INC-2016298666 | PFIZER | 67.00 | YR | F | Y | 0.00000 | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403831 | 12540383 | 1 | PS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | UNK | U | 19115 | ||||||||||
| 125403831 | 12540383 | 2 | SS | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | UNK | U | 0 | ||||||||||
| 125403831 | 12540383 | 3 | SS | CEPHALOSPORIN NOS | UNSPECIFIED INGREDIENT | 1 | UNK | U | 0 | ||||||||||
| 125403831 | 12540383 | 4 | SS | ETODOLAC. | ETODOLAC | 1 | UNK | U | 0 | ||||||||||
| 125403831 | 12540383 | 5 | SS | HYDROCODONE | HYDROCODONE | 1 | UNK | U | 0 | ||||||||||
| 125403831 | 12540383 | 6 | SS | RISEDRONATE SODIUM. | RISEDRONATE SODIUM | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125403831 | 12540383 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |